The World Health Organization (WHO) has officially acknowledged receipt of a notification from the United States signaling its intent to withdraw from the international body, an action that prompts profound reflection on decades of collaborative public health endeavors. This development marks a pivotal moment for global health governance, with the United Nations specialized agency expressing considerable regret over the decision, framing it as a move that could compromise both American and worldwide safety in the face of persistent and emerging health threats. The formal notification sets in motion a procedural review, with the matter slated for consideration by the WHO Executive Board during its scheduled meeting commencing February 2, and subsequently by the World Health Assembly at its annual session in May 2026. This timeline underscores the intricate legal and diplomatic processes inherent in such a significant disengagement from a global multilateral institution.
Historically, the United States has been an indispensable pillar of the World Health Organization, participating as a foundational member since the WHO’s establishment in 1948. Its engagement has been instrumental in numerous monumental public health achievements that have fundamentally reshaped global health landscapes. From the ambitious global campaign that culminated in the eradication of smallpox – a devastating disease that claimed millions of lives over centuries – to significant strides against formidable adversaries like poliomyelitis, HIV/AIDS, Ebola virus disease, and various strains of influenza, American scientific expertise, financial backing, and diplomatic leadership have consistently played a crucial role. Furthermore, U.S. contributions have been vital in combating persistent global health challenges such as tuberculosis, malaria, neglected tropical diseases, the escalating threat of antimicrobial resistance, and ensuring food safety standards across borders. These collaborative efforts highlight a shared commitment to improving health outcomes worldwide, transcending national boundaries. The WHO’s statement, therefore, implicitly underscores the potential void that could arise from the withdrawal of such a long-standing and impactful partner.
In its communication outlining the rationale for withdrawal, the U.S. government articulated several criticisms against the WHO, including allegations that the organization had "trashed and tarnished" its reputation, insulted its sovereignty, and compromised its independence. The WHO, in its official response, categorically refutes these assertions. The agency emphasized its consistent approach of engaging with all 194 Member States, including the United States, in a spirit of good faith and with unwavering respect for national sovereignty. This stance is central to the WHO’s operational philosophy, which mandates impartial service to all countries without bias or favor, a principle critical for a body tasked with coordinating global responses to health crises that affect diverse nations.
A primary driver cited by the United States for its decision was what it termed "WHO failures during the COVID-19 pandemic," specifically alleging that the organization obstructed the timely and accurate sharing of critical information and subsequently "concealed those failures." The WHO, while acknowledging that no organization or government navigated the unprecedented global health crisis flawlessly, firmly defends its comprehensive response. The organization maintains that throughout the pandemic, it acted with urgency and transparency, disseminating all available information rapidly and openly to the international community. Its guidance to Member States was consistently based on the best available scientific evidence at the time, evolving as new data emerged. It is important to note that while the WHO recommended crucial public health measures such as the use of masks, vaccination, and physical distancing, it deliberately refrained from issuing mandates for these interventions. The agency’s role, as articulated, was to provide evidence-based recommendations, supporting sovereign governments in making policy decisions they deemed most appropriate for their respective populations, thereby upholding national autonomy in public health policy.
The timeline of the WHO’s initial actions in response to the emergent COVID-19 threat further illustrates its proactive stance. On December 31, 2019, immediately upon receiving the first reports of a cluster of "pneumonia of unknown cause" in Wuhan, China, the WHO promptly initiated inquiries for more detailed information and activated its internal emergency incident management system. By January 11, 2020, when China reported the first death associated with the mysterious illness, the WHO had already formally alerted the global community through its official channels, public statements, and social media platforms. Concurrently, it had convened global experts to assess the situation and had published extensive guidance for countries on safeguarding their populations and health systems. A pivotal moment occurred on January 30, 2020, when the WHO Director-General declared COVID-19 a Public Health Emergency of International Concern (PHEIC) under the International Health Regulations – the highest level of alert in international health law. At this juncture, fewer than 100 cases and no reported deaths had occurred outside of mainland China, underscoring the early timing of the declaration aimed at galvanizing a global preventative response.
In the critical initial weeks and months following the PHEIC declaration, the Director-General repeatedly urged all nations to take swift and decisive action to protect their citizens. His warnings were stark and unambiguous, emphasizing that "the window of opportunity is closing," declaring "this is not a drill," and famously describing COVID-19 as "public enemy number one." These pronouncements were designed to convey the gravity of the situation and impress upon national leaders the urgent need for preparedness and coordinated action before the virus’s widespread global proliferation.
In the aftermath of the pandemic’s emergency phase, and in response to numerous independent reviews assessing the global response, including the WHO’s performance, the organization has undertaken significant internal reforms. These initiatives aim to strengthen its own operational capacities and to enhance its support for countries in bolstering their national pandemic preparedness and response frameworks. The WHO points to the continuous operation of systems developed and managed before, during, and after the acute phase of the pandemic as evidence of its ongoing commitment to global health security, benefiting all nations, including the United States. These systems encompass surveillance, early warning mechanisms, and technical support networks, operating 24/7 to monitor and respond to health threats.
Another specific criticism leveled by the United States alleged that the WHO pursued a "politicized, bureaucratic agenda driven by nations hostile to American interests." The WHO vehemently denies this claim, reiterating its foundational identity as a specialized agency of the United Nations. Governed by its 194 Member States, the organization asserts its unwavering impartiality and its core mission to serve all countries without political favoritism or fear of reprisal. Its constitutional mandate is to function as a neutral technical and coordinating body, facilitating global health cooperation, rather than acting as an instrument for the political agendas of individual states. This commitment to neutrality is deemed essential for maintaining the trust and participation of its diverse global membership.
The WHO expressed profound appreciation for the ongoing support and active engagement of its remaining Member States. These nations continue to collaborate within the WHO framework to devise and implement solutions for the world’s most pressing health threats, encompassing both communicable and non-communicable diseases. A notable recent achievement reflecting this commitment to multilateralism is the adoption of the WHO Pandemic Agreement by Member States last year. Once ratified, this landmark instrument of international law is poised to significantly enhance global preparedness and response capabilities for future pandemics, fostering greater equity and solidarity. Furthermore, Member States are currently engaged in crucial negotiations for an annex to this agreement, known as the Pathogen Access and Benefit Sharing system. If adopted, this system would promote the rapid detection and transparent sharing of pathogens with pandemic potential, alongside ensuring equitable and timely access to essential vaccines, therapeutics, and diagnostics for all countries.
Despite the current notification of withdrawal, the World Health Organization articulated a hopeful outlook for the future, expressing its aspiration for the United States to eventually resume active participation within the organization. In the interim, the WHO remains steadfastly dedicated to its core mission and constitutional mandate: to work collaboratively with all countries in pursuit of the highest attainable standard of health as a fundamental human right for every individual on the planet. This enduring commitment underscores the organization’s view that global health challenges necessitate collective action, irrespective of geopolitical shifts.
About the Author
